Role of intestinal microecological dysregulation in development of metabolic-associated fatty liver disease
Metabolic-associated fatty liver disease (MAFLD) is a serious public health threat and its pathogenesis is still not completely clear. Studies have shown that the intestinal microbiota and its metabolites have an important role in the development of MAFLD. In this review, we focus on the key mechanisms by which the intestinal microbiota and its metabolites influence MAFLD. In addition, we also discuss the treatment of MAFLD by modulating the intestinal microbiota through probiotics, prebiotics, synbiotics, and fecal microbiota transplantation.
万方数据
